In light of this interesting result, we suspected that the secreted LOXL4 may bind with cell-surface annexin A2 and catalyze it, resulting in integrin β-1 enrichment on the cell surface, which could work to promote the progression of breast cancer. Here, LOXL4 is linked to breast cancer.